0YX0 Stock Overview
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 0YX0 from our risk checks.
Sysmex Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥14.60 |
| 52 Week High | JP¥22.80 |
| 52 Week Low | JP¥13.20 |
| Beta | 0.54 |
| 1 Month Change | 2.10% |
| 3 Month Change | -6.41% |
| 1 Year Change | -26.51% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -62.03% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0YX0 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -4.6% | 0.7% | 2.5% |
| 1Y | -26.5% | -4.6% | 6.0% |
Return vs Industry: 0YX0 underperformed the German Medical Equipment industry which returned -4.6% over the past year.
Return vs Market: 0YX0 underperformed the German Market which returned 6% over the past year.
Price Volatility
| 0YX0 volatility | |
|---|---|
| 0YX0 Average Weekly Movement | 6.7% |
| Medical Equipment Industry Average Movement | 4.6% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 0YX0 has not had significant price volatility in the past 3 months.
Volatility Over Time: 0YX0's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 9,500 | Hisashi Ietsugu | www.sysmex.co.jp |
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.
Sysmex Corporation Fundamentals Summary
| 0YX0 fundamental statistics | |
|---|---|
| Market cap | €9.69b |
| Earnings (TTM) | €295.77m |
| Revenue (TTM) | €2.75b |
32.8x
P/E Ratio3.5x
P/S RatioIs 0YX0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0YX0 income statement (TTM) | |
|---|---|
| Revenue | JP¥461.51b |
| Cost of Revenue | JP¥219.01b |
| Gross Profit | JP¥242.50b |
| Other Expenses | JP¥192.86b |
| Earnings | JP¥49.64b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 79.61 |
| Gross Margin | 52.54% |
| Net Profit Margin | 10.76% |
| Debt/Equity Ratio | 6.6% |
How did 0YX0 perform over the long term?
See historical performance and comparison